IMPPAT Phytochemical information: 
Tafluposide
Tafluposide
Summary

SMILES: COc1cc(cc(c1OP(=O)(O)O)OC)[C@H]1[C@H]2C(=O)OC[C@@H]2[C@@H](c2c1cc1OCOc1c2)O[C@@H]1O[C@@H]2CO[C@H](O[C@H]2[C@@H]([C@H]1OC(=O)COc1c(F)c(F)c(c(c1F)F)F)OC(=O)COc1c(F)c(F)c(c(c1F)F)F)C
InChI: InChI=1S/C45H35F10O20P/c1-13-64-9-22-39(70-13)42(72-23(56)10-65-40-33(52)29(48)27(46)30(49)34(40)53)43(73-24(57)11-66-41-35(54)31(50)28(47)32(51)36(41)55)45(71-22)74-37-16-7-19-18(68-12-69-19)6-15(16)25(26-17(37)8-67-44(26)58)14-4-20(62-2)38(21(5-14)63-3)75-76(59,60)61/h4-7,13,17,22,25-26,37,39,42-43,45H,8-12H2,1-3H3,(H2,59,60,61)/t13-,17+,22-,25-,26+,37-,39-,42+,43-,45+/m1/s1
InChIKey: RTJVUHUGTUDWRK-CSLCKUBZSA-N
DeepSMILES: COcccccc6OP=O)O)O))))OC))))[C@H][C@H]C=O)OC[C@@H]5[C@@H]cc9ccOCOc5c9)))))))))O[C@@H]O[C@@H]CO[C@H]O[C@H]6[C@@H][C@H]%10OC=O)COccF)cF)ccc6F))F))F))))))))))OC=O)COccF)cF)ccc6F))F))F))))))))))))C
Scaffold Graph/Node/Bond level: O=C(COc1ccccc1)OC1C(OC2c3cc4c(cc3C(c3ccccc3)C3C(=O)OCC23)OCO4)OC2COCOC2C1OC(=O)COc1ccccc1
Scaffold Graph/Node level: OC(COC1CCCCC1)OC1C(OC2C3CC4OCOC4CC3C(C3CCCCC3)C3C(O)OCC23)OC2COCOC2C1OC(O)COC1CCCCC1
Scaffold Graph level: CC(CCC1CCCCC1)CC1C(CC2C3CC4CCCC4CC3C(C3CCCCC3)C3C(C)CCC23)CC2CCCCC2C1CC(C)CCC1CCCCC1
Functional groups: CC(=O)OC; COC(C)=O; CO[C@@H](C)OC; c1cOCO1; cF; cOC; cOP(=O)(O)O
Chemical classification
ClassyFire Kingdom: Organic compounds
ClassyFire Superclass: Lignans, neolignans and related compounds
ClassyFire Class: Lignan lactones
ClassyFire Subclass: Podophyllotoxins
NP Classifier Biosynthetic pathway: Shikimates and Phenylpropanoids
NP Classifier Superclass: Lignans
Synonymous chemical names:
tafluposide
External chemical identifiers:
CID:9877073; ChEMBL:CHEMBL3989413; FDASRS:QN043X3ZDW; SureChEMBL:SCHEMBL26426
Chemical structure download
2D:2D MOL2D MOL22D SDF
3D:3D MOL3D MOL23D SDF3D PDB3D PDBQT
Tafluposide
Physicochemical properties
Property name Tool Property value
Molecular weight (g/mol) RDKit 1116.71
Log P RDKit 5.76
Topological polar surface area (Å2) RDKit 237.96
Number of hydrogen bond acceptors RDKit 18
Number of hydrogen bond donors RDKit 2
Number of carbon atoms RDKit 45
Number of heavy atoms RDKit 76
Number of heteroatoms RDKit 31
Number of nitrogen atoms RDKit 0
Number of sulfur atoms RDKit 0
Number of chiral carbon atoms RDKit 10
Stereochemical complexity RDKit 0.22
Number of sp hybridized carbon atoms RDKit 0
Number of sp2 hybridized carbon atoms RDKit 27
Number of sp3 hybridized carbon atoms RDKit 18
Shape complexity RDKit 0.4
Number of rotatable bonds RDKit 17
Number of aliphatic carbocycles RDKit 1
Number of aliphatic heterocycles RDKit 4
Number of aliphatic rings RDKit 5
Number of aromatic carbocycles RDKit 4
Number of aromatic heterocycles RDKit 0
Number of aromatic rings RDKit 4
Total number of rings RDKit 9
Number of saturated carbocycles RDKit 0
Number of saturated heterocycles RDKit 3
Number of saturated rings RDKit 3
Number of Smallest Set of Smallest Rings (SSSR) RDKit 9
Tafluposide
Drug-likeness properties
Property nameToolProperty value
Number of Lipinski’s rule of 5 violations RDKit 3
Lipinski’s rule of 5 filter RDKit Failed
Number of Ghose filter violations RDKit 4
Ghose filter RDKit Failed
Veber filter RDKit Bad
Pfizer 3/75 filter RDKit Bad
GSK 4/400 filter RDKit Bad
Weighted quantitative estimate of drug-likeness (QEDw) score RDKit 0.036
Tafluposide
ADMET properties
Property nameToolProperty value
Bioavailability score SwissADME 0.11
Solubility class [ESOL] SwissADME Poorly soluble
Solubility class [Silicos-IT] SwissADME Insoluble
Blood Brain Barrier permeation SwissADME No
Gastrointestinal absorption SwissADME Low
Log Kp (Skin permeation, cm/s) SwissADME -9.68
Number of PAINS structural alerts SwissADME 0.0
Number of Brenk structural alerts SwissADME 4.0
CYP1A2 inhibitor SwissADME No
CYP2C19 inhibitor SwissADME No
CYP2C9 inhibitor SwissADME Yes
CYP2D6 inhibitor SwissADME No
CYP3A4 inhibitor SwissADME No
P-glycoprotein substrate SwissADME Yes